This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jan;138(1):34-6.

doi: 10.1053/j.gastro.2009.11.034. Epub 2009 Nov 21.

Do differences in pegylation of interferon alfa matter?

PMID: 19932662
DOI: 10.1053/j.gastro.2009.11.034

Editorial

Do differences in pegylation of interferon alfa matter?

Stefan Zeuzem. Gastroenterology. 2010 Jan.

. 2010 Jan;138(1):34-6.

doi: 10.1053/j.gastro.2009.11.034. Epub 2009 Nov 21.

Author

PMID: 19932662
DOI: 10.1053/j.gastro.2009.11.034

No abstract available

PubMed Disclaimer

Comment on

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.
Rumi MG, Aghemo A, Prati GM, D'Ambrosio R, Donato MF, Soffredini R, Del Ninno E, Russo A, Colombo M. Rumi MG, et al. Gastroenterology. 2010 Jan;138(1):108-15. doi: 10.1053/j.gastro.2009.08.071. Epub 2009 Sep 18. Gastroenterology. 2010. PMID: 19766645 Clinical Trial.
Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection.
Ascione A, De Luca M, Tartaglione MT, Lampasi F, Di Costanzo GG, Lanza AG, Picciotto FP, Marino-Marsilia G, Fontanella L, Leandro G. Ascione A, et al. Gastroenterology. 2010 Jan;138(1):116-22. doi: 10.1053/j.gastro.2009.10.005. Epub 2009 Oct 20. Gastroenterology. 2010. PMID: 19852964 Clinical Trial.

Similar articles

Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
Lo Nigro L, La Spina M, Mirabile E, Pisana P, Schilirò G, Guardo P. Lo Nigro L, et al. Pediatr Blood Cancer. 2004 Aug;43(2):185. doi: 10.1002/pbc.20084. Pediatr Blood Cancer. 2004. PMID: 15236293 No abstract available.
[Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
[No authors listed] [No authors listed] MMW Fortschr Med. 2002 Sep 19;144(38):59. MMW Fortschr Med. 2002. PMID: 12395712 German. No abstract available.
Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
Santin M, Shaw E. Santin M, et al. Lancet. 2002 Jan 19;359(9302):263; author reply 264. doi: 10.1016/S0140-6736(02)07428-7. Lancet. 2002. PMID: 11812596 No abstract available.
[Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C].
Han KH, Yoon YH. Han KH, et al. Korean J Hepatol. 2004 Jun;10(2):81-7. Korean J Hepatol. 2004. PMID: 15218341 Review. Korean. No abstract available.
[Differential effects of interferon-based treatments in chronic hepatitis C].
Nakamoto Y, Kaneko S. Nakamoto Y, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):485-7. Nihon Rinsho. 2004. PMID: 15359846 Review. Japanese. No abstract available.

See all similar articles

Cited by

Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
Rosen I, Kori M, Eshach Adiv O, Yerushalmi B, Zion N, Shaoul R. Rosen I, et al. World J Gastroenterol. 2013 Feb 21;19(7):1098-103. doi: 10.3748/wjg.v19.i7.1098. World J Gastroenterol. 2013. PMID: 23467199 Free PMC article.
Which is the IDEAL peginterferon for Hepatitis C: a meta-analysis of both pegylated interferons in the treatment of HCV-infected patients.
Tacke F. Tacke F. Hepat Mon. 2010 Summer;10(3):229-30. Epub 2010 Sep 1. Hepat Mon. 2010. PMID: 22308143 Free PMC article. No abstract available.
Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study.
Agarwal SK, Bhowmik D, Mahajan S, Bagchi S. Agarwal SK, et al. Indian J Nephrol. 2016 Jul-Aug;26(4):244-51. doi: 10.4103/0971-4065.172228. Indian J Nephrol. 2016. PMID: 27512295 Free PMC article.
Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.
Aghemo A, Rumi MG, Colombo M. Aghemo A, et al. Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):485-94. doi: 10.1038/nrgastro.2010.101. Epub 2010 Jul 20. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20644567 Review.
Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study.
Tran HA, Jones TL, Gibson R, Reeves GE. Tran HA, et al. BMC Endocr Disord. 2011 May 24;11:10. doi: 10.1186/1472-6823-11-10. BMC Endocr Disord. 2011. PMID: 21605462 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science